Aceso Life Science Group Equity 2024

Aceso Life Science Group Aktienanalyse

What does Aceso Life Science Group do?

Aceso Life Science Group Ltd is a UK-based company specializing in the field of medical cannabis. The company was founded in 2016 when the founders recognized the growing demand for medical cannabis and decided to utilize their expertise in this area to establish a company focused on the development and marketing of cannabis products. Aceso's business model is based on various pillars. On one hand, the company offers product design and research and development in the field of medical cannabis products. Aceso also provides various services to help other companies and research institutions develop and bring their own commercial products to market. The company also has a strong presence in retail, where it offers a wide range of cannabinoid products. Aceso Life Science Group has various divisions that focus on the production of medical cannabis products. This includes the manufacturing of medical cannabinoids, which involves the preparation of cannabis oil and other products. Aceso also offers various types of medical cannabis, such as different THC and CBD-based products, and has also developed a special line of products targeting women. Aceso also has a strong presence in research and development, with a dedicated department focused on the development of new and improved cannabinoid products. Aceso's research department works closely with academic research institutions and other organizations to investigate and improve the efficacy and safety of medical cannabis and its derivatives. The products offered by Aceso primarily include medical oils, capsules, tinctures, and creams. These products contain a wide range of cannabinoids, such as CBD, THC, CBG, and CBN, which can be used to treat various conditions. Aceso has also developed a special series of products targeting women, including specific vaginal creams that can be used to treat pain and discomfort associated with the menstrual cycle and other conditions. Overall, Aceso Life Science Group Ltd has established itself as a leading company in the field of medical cannabis products. The company has developed a wide range of products and services aimed at providing its customers with a safe and effective way to treat various conditions. With a strong retail presence and a dedicated research department, Aceso has everything it needs to continue to play a pioneering role in the medical cannabis industry. Aceso Life Science Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Aceso Life Science Group's Equity

Aceso Life Science Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aceso Life Science Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aceso Life Science Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aceso Life Science Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aceso Life Science Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aceso Life Science Group stock

What is the equity of Aceso Life Science Group this year?

Aceso Life Science Group has equity of 0 HKD this year.

What was the equity of Aceso Life Science Group compared to the previous year?

The equity of Aceso Life Science Group has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of Aceso Life Science Group?

A high equity is advantageous for investors of Aceso Life Science Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Aceso Life Science Group?

A low equity can be a risk for investors of Aceso Life Science Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Aceso Life Science Group affect the company?

An increase in equity of Aceso Life Science Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Aceso Life Science Group affect the company?

A reduction in equity of Aceso Life Science Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Aceso Life Science Group?

Some factors that can affect the equity of Aceso Life Science Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Aceso Life Science Group so important for investors?

The equity of Aceso Life Science Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Aceso Life Science Group take to change the equity?

To change equity, Aceso Life Science Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Aceso Life Science Group pay?

Over the past 12 months, Aceso Life Science Group paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 28.79 %. For the coming 12 months, Aceso Life Science Group is expected to pay a dividend of 0 HKD.

What is the dividend yield of Aceso Life Science Group?

The current dividend yield of Aceso Life Science Group is 28.79 %.

When does Aceso Life Science Group pay dividends?

Aceso Life Science Group pays a quarterly dividend. This is distributed in the months of September, September, September, September.

How secure is the dividend of Aceso Life Science Group?

Aceso Life Science Group paid dividends every year for the past 0 years.

What is the dividend of Aceso Life Science Group?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aceso Life Science Group located?

Aceso Life Science Group is assigned to the 'Finance' sector.

Wann musste ich die Aktien von Aceso Life Science Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aceso Life Science Group from 9/2/2009 amounting to 0.012 HKD, you needed to have the stock in your portfolio before the ex-date on 8/14/2009.

When did Aceso Life Science Group pay the last dividend?

The last dividend was paid out on 9/2/2009.

What was the dividend of Aceso Life Science Group in the year 2023?

In the year 2023, Aceso Life Science Group distributed 0 HKD as dividends.

In which currency does Aceso Life Science Group pay out the dividend?

The dividends of Aceso Life Science Group are distributed in HKD.